Literature DB >> 12463418

The stability factor: importance in formulation development.

Rajesh Krishnamurthy1, Mark C Manning.   

Abstract

Efficient development of stable formulations of protein pharmaceuticals requires an intimate knowledge of the protein and its chemical and physical properties. In particular, understanding the mechanisms by which a protein could degrade is critical for designing and testing formulations. This review describes the major pathways by which proteins can degrade, including denaturation, aggregation, oxidation, and interfacial damage. The methods to detect the degradation are covered, along with generalized strategies to retard or prevent each type of decomposition. Without an appreciation of the current best practices for devising stable formulations, the formulation process will be neither efficient nor optimal.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12463418     DOI: 10.2174/1389201023378229

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  16 in total

Review 1.  Growth factor delivery-based tissue engineering: general approaches and a review of recent developments.

Authors:  Kangwon Lee; Eduardo A Silva; David J Mooney
Journal:  J R Soc Interface       Date:  2010-08-18       Impact factor: 4.118

2.  Coarse-grained strategy for modeling protein stability in concentrated solutions. II: phase behavior.

Authors:  Vincent K Shen; Jason K Cheung; Jeffrey R Errington; Thomas M Truskett
Journal:  Biophys J       Date:  2005-12-30       Impact factor: 4.033

3.  Coarse-grained strategy for modeling protein stability in concentrated solutions.

Authors:  Jason K Cheung; Thomas M Truskett
Journal:  Biophys J       Date:  2005-07-22       Impact factor: 4.033

4.  FTIR and nDSC as analytical tools for high-concentration protein formulations.

Authors:  Susanne Matheus; Wolfgang Friess; Hanns-Christian Mahler
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

5.  Coarse-grained strategy for modeling protein stability in concentrated solutions. III: directional protein interactions.

Authors:  Jason K Cheung; Vincent K Shen; Jeffrey R Errington; Thomas M Truskett
Journal:  Biophys J       Date:  2007-03-30       Impact factor: 4.033

Review 6.  Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  BioDrugs       Date:  2010-02-01       Impact factor: 5.807

Review 7.  Nanofibrous scaffolds for dental and craniofacial applications.

Authors:  M J Gupte; P X Ma
Journal:  J Dent Res       Date:  2011-08-09       Impact factor: 6.116

8.  Does the oxidation of methionine in thrombomodulin contribute to the hypercoaguable state of smokers and diabetics?

Authors:  Wesley E Stites; Jeffrey W Froude
Journal:  Med Hypotheses       Date:  2006-10-24       Impact factor: 1.538

Review 9.  Effects of glycosylation on the stability of protein pharmaceuticals.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

Review 10.  Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation.

Authors:  Kruti S Soni; Swapnil S Desale; Tatiana K Bronich
Journal:  J Control Release       Date:  2015-11-10       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.